Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infections and plays a role in prostatic carcinogenesis and prostate cancer (PCa) progression. However, the mechanisms through which UPEC promotes PCa development and progression are unclear. Cytotoxic necrotizing factor 1 (CNF1) is one of the most important UPEC toxins and its role in PCa progression has never been studied. We found that UPEC-secreted CNF1 promoted the migration and invasion of PCa cells and PCa metastasis. In vitro studies showed that CNF1 promotes pro-migratory and pro-invasive activity through entering PCa cells and activating Cdc42, which subsequently induced PAK1 phosphorylation and upregulation of MMP-9 expression. CNF1 also promoted pulmonary metastasis in a xenograft mouse model through these mechanisms. PAK1 phosphorylation correlated with advanced grades of PCa in human clinical PCa tissues. These results suggest that CNF1 derived from UPEC plays an important role in PCa progression through activating a Cdc42-PAK1 signal axis and upregulating the expression of MMP-9. Therefore, surveillance for and treatment of cnf1-carrying UPEC strains may diminish PCa progression and thus have an important clinical therapeutic impact.
Introduction
Uropathogenic Escherichia coli (UPEC) is the leading cause of urinary tract infections (UTIs), accounting for most community (~95%) and hospital acquired (~50%) infections [1] . UTIs caused by UPEC can induce cystitis, pyelonephritis and prostatitis [2, 3] . In addition to being frequently isolated from urine samples of patients with cystitis and pyelonephritis, UPEC is also detected in urine, prostatic secretions and seminal fluids of patients with prostate cancer (PCa), benign prostatic hyperplasia (BPH) and prostatitis [4, 5] .
PCa is one of the most common cancers in the western world [6] . In the United
States, approximately 2.8 million men are diagnosed with PCa each year, which represents 4 in 10 male cancer survivors and 1 in 5 of all cancer survivors [7] . In 2016, it is estimated that there will be 180,890 new PCa cases and 26,120 PCa-related deaths in the United States, resulting in PCa as being the most common form of cancer (21%) and ranking as the second most frequent cause of cancer-related death (8%) [8] . Although PCa is not the most common cancer in China, its incidence and mortality rates are rapidly increasing [9] . The five-year relative survival rate for localized PCa is very high; however, it is low for men with advanced PCa [8] .
UPEC infection of male C3H/HeOuJ mice results in prostatic intraepithelial neoplasia (PIN) at 12 weeks, and high-grade prostate dysplasia and invasive PCa 26 weeks after infection [10] . UPEC can accelerate prostatic carcinogenesis induced by 2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine (PhIP), a dietary carcinogen, and reduces the survival of rats [11] . Pro-oncogenic epithelial changes were found in the This article is protected by copyright. All rights reserved. 6 prostates of C57BL/6J mice 8 weeks post-infection with UPEC [12] . In the genetically engineered Hi-Myc murine PCa model, significantly more UPEC-infected mice had invasive cancer compared to saline-treated mice [12] .
Cytotoxic necrotizing factor 1 (CNF1) is a key UPEC toxin. After binding to the surface of epithelial cells, CNF1 is internalized by endocytosis and subsequently transferred to an endosomal compartment, resulting in the enzymatic domain of CNF1 being translocated into the cytoplasm [13, 14] . CNF1 induces deamidation of specific glutamine residues of several Rho GTPases including RhoA, Rac1 and Cdc42, resulting in their activation and cell motility [15] [16] [17] [18] . The cnf1 gene can be detected in UPEC strains isolated from patients with prostatitis and in tissue samples of BPH [3, 19, 20] . The prevalence of cnf1 in UPEC strains from prostatitis samples is higher than that of samples from cystitis and pyelonephritis [5] . It has also been reported that the prevalence of E. coli strains harboring cnf1 is higher in biopsies of patients with colorectal cancer than patients with diverticulosis, which implies a role of CNF1 in cancer [21] .
In this study, we investigated the role of CNF1 in the motility and invasiveness of PCa cells and PCa metastasis and explored the signaling mechanisms through which CNF1 achieved its activity in PCa progression.
This article is protected by copyright. All rights reserved. 8 identified by LC-MS/MS: The corresponding band was excised and subjected to in-gel digestion. Resulting peptides were separated by reverse phase liquid chromatography on an easy-nLC 1000 system (ThermoFisher Scientific, Waltham, MA, USA) and directly sprayed into a Q-Exactive mass spectrometer (ThermoFisher).
All MS/MS spectra were searched against the Uniprot-ecoli protein sequence database using the PD search engine (version 2.1.0, ThermoFisher) with an overall false discovery rate (FDR) for peptides of less than 1%.
Mutagenesis
Mutagenesis of cnf1, CDC42 and PAK1 were performed by a round circle polymerase chain reaction-based site-directed Fast Mutagenesis System kit (TransGen Biotech, Beijing, China) according to the manufacturer's protocol. The primers used for mutation were WQ0434 to WQ0437, WQ0465-2 to WQ0468 and WQ0561 to WQ0568 (Table S2) .
Wound healing assay
PC3 were grown to 95%-100% confluency and wounds generated with a 200 μL pipette tip, and treated with buffer, LPS or CNF1 (1 nMol/L). Images of wound healing were taken at the indicated time intervals using a microscope (Leica Microsystems, Wetzlar, Germany). The wound area was measured by Image J software.
Transwell migration and invasion assay
Cell migration and invasion assays were performed using Transwell chambers (pore This article is protected by copyright. All rights reserved.
Rho GTPase activation assays
PC3 cells were seeded in 10 cm dishes. After treatment, Cdc42-, Rac1-and RhoAactivation were measured using the respective Activation Assay Biochem Kit (Cdc42: BK034; Rac1: BK035; RhoA: BK036, Cytoskeleton, Dencer CO, USA) according to the manufacturer's protocol.
Antibodies and western blotting
Antibodies were obtained from the following companies: anti-Phospho-PAK1 Cells were washed by PBS three times after treatment with CNF1 or dialysis buffer.
Whole cell lysates were prepared using RIPA lysis buffer (Millipore Billerica, MA, USA), adding complete protease inhibitors and phosphatase inhibitors (Roche, Basel, Switzerland). Protein concentration was determined using the BCA Protein Assay Kit (ThermoFisher) and approximately 40 µg of cell lysates were used. Antibody binding was revealed using an HRP-conjugated anti-rabbit IgG or anti-mouse IgG (Sigma-Aldrich). Antibody complexes were detected using Immobilon Western Chemiluminescent HRP Substrate (Millipore) and exposure to Tanon-5200 machine.
Densitometry was performed using Image J software.
Transduction and transfection
PC3 or 22Rv1 cells stably expressing luciferase were constructed using lentiviral supernatant and selected with puromycin following the manufacturer's instructions.
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Immunohistochemistry (IHC)
Murine lungs were fixed in 4% paraformaldehyde for 24 h and processed for paraffin This article is protected by copyright. All rights reserved.
Chicago, IL, USA), p-PAK1 (Thr423) (1:10, #2601, Cell Signaling Technology) and MMP-9 (1:100, BA0573, BOSTER).
RNA interference
Double-stranded RNAs as siRNAs for targeted genes and Scrambled siRNA (siScr)
were synthesized by GenePharma (Shanghai, China). The sequences (sense strand) of siRNAs are listed in Table S2 . Specific gene knockdowns were assessed by western blotting. Transfection of siRNA was carried out using Lipofectamine 3000 (Invitrogen).
Tissue microarray analysis
The prostate cancer tissue microarray (PR1921a) containing 96 male specimens (8 normal prostate tissue, 8 adjacent normal prostate tissues, and 80 malignant tissues with grade II, II-III or III) was purchased from Alenabio (Xi'an, China). Staining was evaluated as described previously [22] , and the values of staining intensity were determined by Image-Pro Plus software.
Statistical analyses
Data from three independent experiments are presented as the mean ± SD. The statistical significance of differences between groups was calculated using two-tailed student's t-test or one-way analysis of variance using SPSS 22.0 software.
Phylogenetic analysis
The presence of cnf1 was found by screening the genome sequences of 63 UPEC strains used in our previous study [23] . A phylogenetic tree based on the alignments of combined protein sequences from CNF1 was constructed using maximum likelihood
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Results

CNF1 promotes the migration and invasion of prostate cancer cells in vitro
Recombinant CNF1 derived from UPEC strain 11 was purified and validated using mass-spectrography (Table S3 ). PC3 cells were treated with CNF1, LPS or the dialysis buffer as control and then subjected to a wound healing assay. CNF1 induced migration in a dose-and time-dependent manner ( Figure 1A It has been reported that cysteine 866 and histidine 881 are functional essential amino acid residues of CNF1 [24] . C866S mutation completely eliminated CNF1's pro-migratory and pro-invasive effects, while H881Q partially blocked activity ( Figure 1G , H and Figure S1C ). Taken together, these results provide strong evidence that CNF1 has pro-migratory and pro-invasive activity on PCa cells.
CNF1 promotes the in vivo metastasis of prostate cancer cells
The effect of CNF1 on metastasis of PC3 cells was analyzed in vivo using a xenograft
This article is protected by copyright. All rights reserved. Luciferase labeled 22Rv1 cells treated with CNF1 or CNF1-C866S were injected into the prostate of NOD/SCID mice. Seven weeks after injection, mice receiving 22Rv1-luci cells treated with CNF1 had a higher level of metastasis ( Figure 2D and Figure S2E ).
CNF1 activates Rho GTPases in prostate cancer cells
To determine whether CNF1 can enter PCa cells, we treated PC3 cells with CNF1 for
h and performed immunofluorescence (IF) for CNF1 protein. There was
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accumulation of CNF1 protein in the cytoplasm ( Figure 3A) . We also verified the intracellular presence of CNF1 using western blotting ( Figure 3B ).
We examined the activation levels of the main three Rho-GTPase family members, (RhoA, Cdc42 and Rac1) induced by CNF1 using a pull down assay. RhoA, Cdc42
and Rac1 were activated in PC3 cells treated by CNF1; and among the three GTPases, CNF1's affect was stronger on Cdc42 and Rac1 compared to RhoA (Figure 3C-E) .
CNF1 promotes the migration and invasion of prostate cancer cells through Cdc42
We hypothesized that CNF1 promoted the motility and invasive properties of PCa cells by activating Rho GTPases, which regulate actin cytoskeletal re-arrangement [25] . We blocked the three GTPases using inhibitors ( Figure S3A ) and found that enhancement of motility and invasion by CNF1 was attenuated in a dose-dependent manner by inhibiting Cdc42, but not Rac1. Inhibition of RhoA reduced PC3 migration and invasion in both the CNF1 treated and control groups ( Figure 4A -F).
Cdc42 expression was knocked down using siRNAs ( Figure 4G , Figure S3B ). The migration and invasion of Cdc42 knocked-down PC3 cells treated with CNF1 was significantly diminished compared to siScr control ( Figure 4H, I ). Two other siRNAs targeting different sites of Cdc42 were used to verify our observations ( Figure S3C , D). RhoA and Rac1 were also knocked down using siRNA, which did not affect the This article is protected by copyright. All rights reserved. 
Cdc42-mediated phosphorylation of PAK1 is essential for the enhancement of prostate cancer cell migration and invasion induced by CNF1
Group I p21-activated kinase 1 (PAK1) is an important effector of the small GTPase Cdc42 [26] , and acts as an important regulator of cytoskeletal dynamics and cell motility [27] . To determine pro-migratory and pro-invasive effects of CNF1 on PC3 cells, we blocked this pathway with the PAK1 inhibitor (IPA3) [28] . Exposure of CNF1-treated PC3 cells to IPA3 decreased their migration and invasion in a dose-dependent manner ( Figure 5A , B), indicating that CNF1 promotes these activities through PAK1. Thr423 phosphorylation is required for full activation of This article is protected by copyright. All rights reserved.
PAK1 [28] and we found elevated phosphorylation of PAK1 at Thr423 after treatment with CNF1 ( Figure 5C ). Elevated phosphorylation of PAK1 was also identified in 22Rv1 cells treated with CNF1 ( Figure 5D ).
To As we identified that CNF1 mediates its activity, in part, through Cdc42, we next investigated whether PAK1 activation is directly mediated by Cdc42 activation. The
Cdc42 inhibitor CID44216842 inhibited phosphorylation of PAK1 ( Figure 5H ), and increased PAK1 phosphorylation was found in PC3 and 22Rv1 cells transfected with CA-Cdc42 compared to those transfected with Cdc42 or DN-Cdc42 ( Figure 4J , Figure   S4A ). These findings demonstrate that CNF1 activates Cdc42-PAK1 signaling to promote the migration and invasion of prostate cancer cells.
CNF1 upregulates the expression of MMP-9 by activating PAK1
Nearly every member of the matrix metalloproteinases (MMPs) family has been reported to be dysregulated in human cancers, with the gelatinases (MMP-2 and MMP-9) playing a pivotal role in degrading extra-cellular matrix (ECM) [29] . We explored whether the pro-invasive effect is associated with MMP-9 or MMP-2. CNF1
upregulated MMP-9, but had no effect on MMP-2 expression. PAK1 inhibition diminished the ability of CNF1 to upregulate MMP-9 ( Figure 6A ). Increased MMP9 was found in PC3 and 22Rv1 cells transfected with CA-PAK1 compared to PCa cells transfected with PAK1 or DN-PAK1 ( Figure 5E , Figure S5A ). These results demonstrate that CNF1 can upregulate the expression of MMP-9 by activating PAK1.
Inhibition of Cdc42 also significantly reduced the expression of MMP-9, but not of MMP-2 ( Figure 6B ). The level of active Cdc42, PAK1 phosphorylation and MMP-9 expression were also upregulated in PC3 cells with CNF1c overexpression compared to those with CNF1c-C866S or the control vector ( Figure S2F ). These results demonstrate that CNF1 can drive migration and invasion of PCa cells through the
Cdc42-PAK1-MMP-9 pathway in vitro.
To further validate the role for CNF1 in promoting PCa invasion through PAK1 and MMP-9, we performed IHC analysis of lung tissue from the experimental mice described previously. MMP-9 and phosphorylated PAK1 expression were present in pulmonary metastasis of mice injected by PC3 cells with CNF1c expression ( Figure   6C ). These results suggest a key role for the Cdc42-PAK1-MMP-9 signaling axis in CNF1-induced PCa aggressiveness in vivo.
Activation of PAK1 is positively correlated with advanced human prostate cancer
The expression of phosphorylated PAK1 was analyzed by IHC using a human tissue array containing 96 samples, which include 80 PCa tissues with grade II, II-III, or III.
The percentage of samples with phosphorylated PAK1 staining in malignant tissues
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was higher than those in normal and adjacent normal tissues and was positively correlated with the histological grades of PCa ( Figure 6D , E). We also found that the levels of phosphorylated PAK1 were strongly correlated with PCa grades (Figure 6F ), and the positive percentage of samples with strong staining was higher in grade III and II-III than in grade II ( Figure 6G ). These results indicate that PAK1 activation is correlated with PCa advanced grades.
CNF1 derived from other UPECs has similar pro-migratory and pro-invasive effects on prostate cancer cells
We found 11 of 63 UPEC strains with available genome sequences included the cnf1 gene. The 11 CNF1 proteins were separated into two groups, with two different amino acids (N666T, V1001A) in the segment of 515-1014 ( Figure S6A ). We purified another recombinant CNF1 derived from the UPEC strain 1, which belongs to a different UPEC group than the UPEC strain 11. Consistent with the results obtained from the UPEC strain 11-derived CNF1, UPEC strain 1-derived CNF1 also promoted the migration and invasion of PC3 cells ( Figure S6B, C) . Additionally, we detected the effects of Cdc42, Rac1, RhoA, and PAK1 inhibitors on strain 1-derived CNF1-induced cell migration and invasion ( Figure S6D , E). The changes of MMP-9 expression and PAK1 phosphorylation level induced by CNF1 (strain 1) were also examined using western blotting ( Figure S6F ).
Three UPEC strain 11-derived CNF1 mutants: N666T, V1001A and double mutant were created. Wildtype and mutant CNF1-overexpressed E. coli K12 were used to perform phenotype experiments, and no obvious difference was observed on PC3 cell
migration and invasion ( Figure S6G-I ). These findings demonstrate that CNF1 derived from other UPECs has similar pro-migratory and pro-invasive effects on prostate cancer cells and that residues 666 and 1001 do not influence CNF1 activity.
Discussion
In this study, we identified that CNF1 secreted by UPEC could accelerate PCa progression through activating the Cdc42-PAK1 signaling axis ( Figure S7 ). Almost 20% of all cancers are associated with microbial infection [30] , and certain cancer types are promoted by bacteria. Helicobacter pylori is a prime example that bacterial pathogens can drive carcinogenesis, and has been classified as a carcinogen for gastric cancer by Cdc42 expression is upregulated in many kinds of cancers such as breast, colorectal and ovarian cancer [39, 40] . The role of Cdc42 in prostate cancer is rarely reported.
The p21-activated kinases (PAKs) are overexpressed and activated in many human cancers and are positively correlated with advanced grades and decreased survival, and PAK1 is one of the best characterized PAKs dysregulated in cancers [41] . PAK1
upregulates MMP expression in breast cancer cells [42] . Higher expression of PAK1 was found in invasive PCa cells compared to non-invasive PCa cells, and inhibition of PAK1 impaired PC3 cell migration [43] . It was suggested that this effect was caused
by high expression of MMP-9 and low expression of TGF² regulated by PAK1 [43] .
In our study, CNF1 increased the phosphorylation of PAK1 by activating Cdc42, and then upregulated the expression of MMP-9. Upregulation of active PAK1 correlated with advanced-grade PCa using clinical human PCa samples, indicating that active PAK1 is a possible marker, although further experiments are required.
Only UPEC strains CP1 or CP9 have been used to infect the prostate in mouse or rat models in previous reports [11, 12, 44] . In our study, UPEC strain 1 or 11 cannot successfully infect the prostate of NOD/SCID mice and C57BL/6J mice, indicating that UPEC strains used for prostate infection in mouse models are very limited. CNF1
has been reported to enhance inflammation in bladder and prostate [44, 45] , and we also found that bladder inflammation caused by the CNF1 overexpressing K12 stain was greater than that caused by the CNF1 C866S overexpressing K12 stain and the K12 control strain (data not shown). Therefore, in addition to migratory and invasive activity of PCa cells promoted by CNF1, CNF1 inducing inflammation may also promote PCa progression, which needs further studies. Table S1 . Strains and plasmids used in this study
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